Aller au contenu

← Journal/21 July 2026·6 min de lecture

CBD prices in France in 2026: real ranges and the true cost of a compliant product

Par ·

In 2026, a compliant CBD flower sells in shops for between €1.90 and €13 per gram depending on the growing method, and a resin for between €5 and €15. On a French market valued at €600-700 million in 2023 by the Xerfi study, these gaps are anything but arbitrary: they reflect very real production and testing costs. Here is the breakdown, ranges included.

CBD prices in France in 2026: real ranges and the true cost of a compliant product

How much does CBD cost in France in 2026?

There is no official price index for CBD. The ranges below are prices observed in shops and online in mid-2026, for products compliant with the 0.30 % THC threshold. They vary according to the variety, the quantity bought and the distribution channel.

Ranges observed in shops (mid-2026)

CategoryObserved price per gram
Outdoor flower (open field)€1.90 to €5
Greenhouse flower (under glass)€2.90 to €9
Indoor flower (indoors)€6 to €13
Resin / hash€5 to €15

The market behind these prices has changed scale: the Xerfi study devoted to the French CBD market valued it at €600-700 million in 2023 and anticipated it passing the billion mark by 2026. The retail network is estimated, according to trade organisations and the press, at around 2,000 to 2,500 specialist shops in 2023-2024. One important point: since 15 May 2026, ingestible products (food oils, gummies, infusions) have been withdrawn from the French market. These ranges therefore cover only the formats still authorised.

Indoor, greenhouse, outdoor: where do the gaps come from?

The price hierarchy follows the production-cost hierarchy. Indoor growing takes place in a fully controlled environment: horticultural lighting, ventilation, temperature and humidity regulation, labour on site every day. That level of control is paid for in energy and working hours, and it feeds mechanically into the price per gram.

The greenhouse pools natural light with partial climate control: it logically sits between the two. Outdoor, grown in open fields, carries the lowest costs, at the price of dependence on the weather and an often less uniform appearance. None of these methods is better in itself: they answer different budgets and different expectations.

The true cost of a compliant CBD

Beyond growing, a compliant product carries costs that are barely visible. Testing each batch by chromatography (HPLC or LC-MS) comes to somewhere between €90 and €200 per batch, according to information published by NORML France on cannabinoid analysis services. To that you must add sourcing catalogued European varieties, documentary traceability, regulatory labelling and the legal monitoring that a shifting framework demands.

That is the foundation described by our laboratory: every batch sold comes with its analysis. A rock-bottom price almost always means one of these items has been dropped, and it is rarely the marketing one.

"Too cheap": why is that a warning sign?

Looking for an inexpensive CBD flower is entirely legitimate. The problem starts when the price can no longer fund the testing. On 19 June 2025, the ANSM and Anses issued a warning about several hundred cases of poisoning recorded since the start of 2024, caused by products sold as CBD but spiked with synthetic cannabinoids (HHC, HHC-O, H4-CBD) or exceeding 0.30 % THC.

The MILDECA/OFDT study conducted with Lille University Hospital on 223 samples bought in 2022-2023 puts figures on the phenomenon: 69 % of samples contained less CBD than advertised, and only 46 % carried any composition labelling. In addition, 87 % complied with the 0.30 % THC threshold, but 6 % contained undeclared neo-cannabinoids. An abnormally low price increases the likelihood of falling into these categories: our article on synthetic cannabinoids sold as CBD sets out these risks in detail.

Comparing prices properly: the method

Always compare the price per gram at equal quantity: most retailers use sliding scales, and a price displayed for 10 g tells you nothing about the unit price. Then check what the price includes: a batch analysis you can consult, a catalogued variety, CBD and THC contents displayed. Our guide to buying quality CBD in France lists these checks point by point.

The sales channel matters too. Products offered in supermarkets or tobacconists do not always provide the same level of information as a specialist retailer, as our analysis of CBD products sold in supermarkets and tobacconists shows.

Resins and hash: a different reading grid

The resins observed range from €5 to €15 per gram, a spread that reflects the manufacturing method, the CBD concentration and the work of separating out the plant matter. A decent hash requires more raw material than an equivalent flower: a very low price should therefore raise even more questions. To tell pollen, hash and concentrated resins apart before buying, our guide on choosing a CBD resin sets out the useful criteria.

Frequently asked questions

What is the average price of a gram of CBD flower?

It all depends on the growing method: roughly €1.90 to €5 per gram outdoor, €2.90 to €9 greenhouse and €6 to €13 indoor, according to the ranges observed in shops in 2026. Prices generally slide downwards with quantity, and there is no official index.

Why does indoor CBD cost more?

Because indoor growing rests on a fully artificial environment: lighting, ventilation, controlled climate and continuous labour. These items, energy first among them, weigh directly on the production cost per gram. The greenhouse, which benefits from natural light, and the open field sit below.

Why be wary of CBD that is too cheap?

Because public data documents the risk: in June 2025 the ANSM reported several hundred cases of poisoning linked to adulterated products sold as CBD, and the MILDECA study of 223 samples found 69 % of products underdosed. A very low price rarely funds a batch analysis.


Written by the Phytogrammes team

Every article in this journal draws on primary sources (ANSM, EFSA, EUR-Lex, peer-reviewed publications) and on the lab's own practice: batch-by-batch HPLC analyses, measured cannabinoid profiles. Our approach.

Article published on . CBD is not a medicine.

Phytogrammes products that pair well